ArticleExperimental and therapeutic medicine2023

Complete remission of reactive cutaneous capillary endothelial proliferation caused by the programmed cell death-1 inhibitor camrelizumab achieved through thalidomide monotherapy: A case report.

Chunxiu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.